Old Web
English
Sign In
Acemap
>
authorDetail
>
Hiroyoshi Yamazaki
Hiroyoshi Yamazaki
National Patient Safety Foundation
Medicine
Tadalafil
Postmarketing surveillance
Internal medicine
Surgery
5
Papers
15
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A long-term open-label safety study of galcanezumab in Japanese patients with migraine
2021
Expert Opinion on Drug Safety
Koichi Hirata
Takao Takeshima
Fumihiko Sakai
Yoshihisa Tatsuoka
Norihiro Suzuki
Hisaka Igarashi
Tomomi Nakamura
Akichika Ozeki
Hiroyoshi Yamazaki
Vladimir Skljarevski
Show All
Source
Cite
Save
Citations (0)
Real-World Safety and Effectiveness of Tadalafil in Patients with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Japanese Post-Marketing Surveillance Study
2020
Hiroyoshi Yamazaki
Naoto Tsujimoto
Momoha Koyanagi
Megumi C Katoh
Koyuki Tajima
Mika Komori
Show All
Source
Cite
Save
Citations (2)
Safety and effectiveness of tadalafil in patients with pulmonary arterial hypertension: Japanese post-marketing surveillance data
2017
Current Medical Research and Opinion
Hiroyoshi Yamazaki
Noriko Kobayashi
Masanori Taketsuna
Koyuki Tajima
Masahiro Murakami
Show All
Source
Cite
Save
Citations (4)
Safety and effectiveness of tadalafil in pediatric patients with pulmonary arterial hypertension: a sub-group analysis based on Japan post-marketing surveillance
2017
Current Medical Research and Opinion
Hiroyoshi Yamazaki
Noriko Kobayashi
Masanori Taketsuna
Koyuki Tajima
Nahoko Suzuki
Masahiro Murakami
Show All
Source
Cite
Save
Citations (9)
GW26-e0266 Safety and effectiveness of Tadalafil on PAH from a post-marketing surveillance (Investigation on all patients in Japan, interim data)
2015
Journal of the American College of Cardiology
Ping Xin
Masahiro Murakami
Yasuhiro Umeki
Masanori Taketsuna
Nobuyuki Kobayashi
Hiroyoshi Yamazaki
Show All
Source
Cite
Save
Citations (0)
1